Navigation Links
The Convergent Procedure for the Treatment of Chronic Atrial Fibrillation Highlighted at EACTS Annual Meeting in Geneva
Date:9/13/2010

MORRISVILLE, N.C., Sept. 13 /PRNewswire/ -- The Convergent Procedure, a novel approach to treat atrial fibrillation (AF), enabled by epicardial ablation products from nContact Surgical, Inc. (nContact), was highlighted at the Techno-College Atrial Fibrillation Session of the EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting in Geneva, Switzerland. More than 1,000 medical professionals attended the 2010 Techno-College Programme to receive an update on the latest technical advancements in cardiothoracic surgery.

The Convergent Procedure is the first multidisciplinary, closed chest treatment for all types of AF.  During the combined epicardial-endocardial ablation procedure, a cardiac surgeon and an electrophysiologist (EP) work as a team to create a comprehensive bi-atrial lesion pattern, without chest incisions or ports. The surgeon utilizes the nContact coagulation device during epicardial ablation to create continuous, linear lesions on a beating heart. The EP then performs endocardial ablation to complete the pattern and utilizes mapping and diagnostics to ensure lesion completeness and that procedure endpoints are achieved.  

Professor Borut Gersak, Head of Cardiovascular Surgery at the University Medical Center, Ljubljana, Slovenia, presented the Convergent Procedure technique and long-term outcomes of 53 patients at six months and 39 patients at twelve months.  Data from the study confirmed over 90% of patients returned to sinus rhythm at six and twelve months post-procedure.  

Commenting on the positive patient data and advantages of the Convergent Procedure, Professor Gersak stated, "The Convergent Procedure merges the best techniques of two cardiac disciplines into a single, complete epicardial-endocardial approach that offers a new treatment opportunity for persistent and longstanding persistent AF patients."

Professor Gerhard Wimmer-Greinecker, Chief of Cardiac Surgery at the Heart and Vascular Center in Bad Bevensen, Germany, who moderated the session and has performed the Convergent Procedure, commented, "The combined epicardial-endocardial procedure potentially enhances the ability to treat new AF patients, decreases total procedure times, reduces physician skills required, and potentially improves outcomes."

About nContact Surgical, Inc.nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF).  The Numeris® Coagulation System with VisiTrax® is based on the unique integration of suction, perfusion, and RF energy to ensure the creation of visible, non-conductive, continuous, bi-atrial lesions on the epicardium of a beating heart.

To date, the Numeris® Coagulation System with VisiTrax® is indicated for endoscopic coagulation of cardiac tissue in the United States.  nContact has initiated IDE clinical studies for the treatment of AF in both open and closed chest procedures.  The Numeris Coagulation System with VisiTrax has CE Mark approval in Europe for the coagulation of cardiac tissue for the treatment of AF and atrial flutter.Media ContactsnContact Surgical, Inc. Edgar Rey

1001 Aviation Parkway, Ste 400nContact Surgical

Morrisville, NC  27560T (404) 285-0466

T (919) 466-9810 erey@ncontactsurgical.com

F (919) 466-9811Kimberly Muscara/Jason RandoThe Ruth GroupT (646) 536-7011/7025kmuscara@theruthgroup.com
'/>"/>

SOURCE nContact Surgical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices
2. Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction
3. Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures
4. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
5. Leading Cardiovascular Surgeons Gather from Around the World to Share Ross Procedure Survival Data, Techniques at 2nd Annual Summit
6. CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China
9. VerteLoc™ Tops 500 Surgical Procedures, VGI Announces VerteLX™ and Seeks Potential Investors for Growth
10. DHS Begins Test of Biometric Exit Procedures at Two U.S. Airports
11. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... separable adhesive layers, as issued by the U.S. Patent & Trademark Office (USPTO). ... to combining electronics and health monitoring. This invention will be critical to the ...
(Date:3/29/2017)...  Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions ... results for the fourth quarter and full year ... a pivotal year for us with our first ... agreements, major reimbursement progress with Medicare, positive medical ... addition we cleared our 2 nd generation ...
(Date:3/29/2017)... year,s petition to the White House signed by 120,000 ... generate awareness on the importance of new organic medicines and nutritional ... place. ... this month Health Advance (OTC PINK: HADV ), ... announced its endeavors on this generally recognized as safe ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... announce that Nerium International Mexico has been approved as an active member of ... achieve satisfaction and protection among distributers and consumers in relationship marketing. This professional ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):